C-bridge Iv Investment Nine Limited - Net Worth and Insider Trading

C-bridge Iv Investment Nine Limited Net Worth

The estimated net worth of C-bridge Iv Investment Nine Limited is at least $303 Million dollars as of 2024-06-23. C-bridge Iv Investment Nine Limited is the 2101 Beneficial owner of Everest Medicines Ltd and owns about 15,277,778 shares of Everest Medicines Ltd (HKSE:01952) stock worth over $303 Million. Details can be seen in C-bridge Iv Investment Nine Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that C-bridge Iv Investment Nine Limited has not made any transactions after 2020-10-09 and currently still holds the listed stock(s).

Transaction Summary of C-bridge Iv Investment Nine Limited

To

C-bridge Iv Investment Nine Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, C-bridge Iv Investment Nine Limited owns 1 companies in total, including Everest Medicines Ltd (HKSE:01952) .

Click here to see the complete history of C-bridge Iv Investment Nine Limited’s form 4 insider trades.

Insider Ownership Summary of C-bridge Iv Investment Nine Limited

Ticker Comapny Transaction Date Type of Owner
HKSE:01952 Everest Medicines Ltd 2020-10-09 2101 Beneficial owner

C-bridge Iv Investment Nine Limited Latest Holdings Summary

C-bridge Iv Investment Nine Limited currently owns a total of 1 stock. C-bridge Iv Investment Nine Limited owns 15,277,778 shares of Everest Medicines Ltd (HKSE:01952) as of October 9, 2020, with a value of $303 Million.

Latest Holdings of C-bridge Iv Investment Nine Limited

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:01952 Everest Medicines Ltd 2020-10-09 15,277,778 19.80 302,500,004

Holding Weightings of C-bridge Iv Investment Nine Limited


C-bridge Iv Investment Nine Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, C-bridge Iv Investment Nine Limited has made a total of 1 transactions in Everest Medicines Ltd (HKSE:01952) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Everest Medicines Ltd is the sale of 15,277,778 shares on October 9, 2020, which brought C-bridge Iv Investment Nine Limited around $0.

Insider Trading History of C-bridge Iv Investment Nine Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

C-bridge Iv Investment Nine Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

C-bridge Iv Investment Nine Limited Ownership Network

Ownership Network List of C-bridge Iv Investment Nine Limited

No Data

Ownership Network Relation of C-bridge Iv Investment Nine Limited

Insider Network Chart

C-bridge Iv Investment Nine Limited Owned Company Details

What does Everest Medicines Ltd do?

Who are the key executives at Everest Medicines Ltd?

C-bridge Iv Investment Nine Limited is the 2101 Beneficial owner of Everest Medicines Ltd. Other key executives at Everest Medicines Ltd include 2307 Founder of a discretionary trust who can infl FU WEI , 2201 Interest of corporation controlled by you Nova Aqua Limited , and 2201 Interest of corporation controlled by you C-Bridge Joint Value Creation Limited .

Everest Medicines Ltd (HKSE:01952) Insider Trades Summary

Over the past 18 months, C-bridge Iv Investment Nine Limited made no insider transaction in Everest Medicines Ltd (HKSE:01952). Other recent insider transactions involving Everest Medicines Ltd (HKSE:01952) include a net sale of 1,468,000 shares made by Nova Aqua Limited , a net sale of 1,468,000 shares made by FU WEI , and a net sale of 0 shares made by Everest Management Holding Co., Ltd. .

In summary, during the past 3 months, insiders sold 0 shares of Everest Medicines Ltd (HKSE:01952) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,936,000 shares of Everest Medicines Ltd (HKSE:01952) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,936,000 shares.

Everest Medicines Ltd (HKSE:01952)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Everest Medicines Ltd Insider Transactions

No Available Data

C-bridge Iv Investment Nine Limited Mailing Address

Above is the net worth, insider trading, and ownership report for C-bridge Iv Investment Nine Limited. Currently GuruFocus does not have mailing address information for C-bridge Iv Investment Nine Limited.

Discussions on C-bridge Iv Investment Nine Limited

No discussions yet.